Clinical Application Status of Articular Cartilage Regeneration Techniques: Tissue-Engineered Cartilage Brings New Hope

Abstract EN

Hyaline articular cartilage lacks blood vessels, lymphatics, and nerves and is characterised by limited self-repair ability following injury.

Traditional techniques of articular cartilage repair and regeneration all have certain limitations.

The development of tissue engineering technology has brought hope to the regeneration of articular cartilage.

The strategies of tissue-engineered articular cartilage can be divided into three types: “cell-scaffold construct,” cell-free, and scaffold-free.

In “cell-scaffold construct” strategies, seed cells can be autologous chondrocytes or stem.

Among them, some commercial products with autologous chondrocytes as seed cells, such as BioSeed®-C and CaReS®, have been put on the market and some products are undergoing clinical trials, such as NOVOCART® 3D.

The stem cells are mainly pluripotent stem cells and mesenchymal stem cells from different sources.

Cell-free strategies that indirectly utilize the repair and regeneration potential of stem cells have also been used in clinical settings, such as TruFit and MaioRegen.

Finally, the scaffold-free strategy is also a new development direction, and the short-term repair results of related products, such as NOVOCART® 3D, are encouraging.

In this paper, the commonly used techniques of articular cartilage regeneration in surgery are reviewed.

By studying different strategies and different seed cells, the clinical application status of tissue-engineered articular cartilage is described in detail.